图书简介
Global health has been challenged with the dawning of the era of the obesity epidemic, and thus as a consequence, strategies to reduce obesity have become public health priorities. According to the United Nations, obesity has been identified as a concern for achieving Sustainable Development Goals. Obesity is a serious health problem with an increased risk of several common diseases including diabetes, cardiovascular disease, and cancer. Although the fundamental cause of obesity and overweight is an imbalance between calorie intake and calorie expenditure, the underlying biochemical and metabolic processes that cause obesity are not fully understood.Two earlier volumes dedicated to the subject of obesity, published in the series “Advances in Biochemistry in Health and Disease” focused on the pathophysiology of obesity-induced health complications and the biochemistry of cardiovascular dysfunction in obesity. This book brings together contributions from international experts in the field to describe advancements on the mechanisms leading to development of obesity and related complications. There are 21 chapters in two different parts in this book, comprising of Part I: Pathophysiologic Mechanisms of Obesity (11 chapters) and Part II: Therapeutic Mechanisms of Obesity (10 chapters). This book will serve as a resource and be of interest to health professionals, medical students, fellows, residents and graduate students. It will also evoke innovative research and effective approaches for the prevention of obesity. This volume will accentuate that obesity is a major health hazard in its own right and that appropriate public health measures should be implemented to prevent or reduce or even reverse the impact of this global chronic disease.
Cellular and biochemical mechanisms of obesity.- The role of inflammation in obesity.- Hypothalamic inflammation and malfunctioning glia in the pathophysiology of obesity.- The role of the inflammasome in obesity.- Adipose tissue macrophages and their polarization in health and obesity.- Adolescent Obesity and Insulin Resistance: Roles of Ectopic Fat Accumulation and Adipose Inflammation.- The interplay between adipocytes and immune system cells in the pathophysiology of obesity.- Neuropeptides in Obesity and Metabolic Disease.- Adiposity and the Role of Neuroendocrine Hormones in Energy Balance.- Obesity in menopause.- Ovarian hormones and obesity.- The role of tissue-specific glucocorticoids in central obesity.- Thyroid function in obesity.- Glucocorticoid hormones: cause or cure for obesity.- Obesity: An overview of possible role(s) of gut hormones, lipid sensing and gut microbiota.- Recent advances in leptin and obesity.- Pathophysiology of obesity due to neurohormonal dysregulation and autophagy.- The Role of the Autonomic Nervous System in the Pathophysiology of Obesity.- Disturbance of neuronal signals in the pathophysiology of obesity.- The sympathetic neuro-adipose connection and the control of body weight.- Sympathetic activation in obesity.- Obesity-associated sympathetic overactivity in children and adolescents: the role of catecholamine resistance in lipid metabolism.- Relevance of Sympathetic Nervous System Activation in Obesity and Metabolic Syndrome.- Should the sympathetic nervous system be a target to improve obesity?.- Metabolic Syndrome and Oxidative Stress: A Complex Relationship.- The role of oxidative stress in the pathogenesis of obesity.- How effective are antioxidant supplements in obesity.- Oxidative stress in obesity: a critical component in human diseases.- Cellular mechanisms involved in the pathophysiology of obesity during oxidative stress.- Oxidative stress and metabolic pathologies: from an adipocentric point of view.- Oxidative stress contributes to the pathogenesis of obesity.- The genetics of oxidative stress in obesity.- Increased oxidative stress is associated with adipocyte fat accumulation.- The vicious cycle of oxidative stress and obesity.- GPCR-Mediated Signaling of Metabolites in the pathophysiology of obesity.- Ceramide signaling in obesity.- The role of the triggering receptor in the pathophysiology of obesity.- The AMPK pathway in the development of obesity.- Interleukin-1 superfamily: Divergent roles in obesity.- Ghrelin Receptor Mutations and Human Obesity.- Sirtuin 1 deacetylase: a key regulator of hepatic lipid metabolism.- JAK/STAT signaling pathway in the development of obesity.- SIRT1 and SIRT3 as mediators for the development of obesity.- Neurosecretory protein GL stimulates food intake, de novo lipogenesis, and onset of obesity.- Interplay between Obesity and cGMP Signaling in adipose tissue.
Trade Policy 买家须知
- 关于产品:
- ● 正版保障:本网站隶属于中国国际图书贸易集团公司,确保所有图书都是100%正版。
- ● 环保纸张:进口图书大多使用的都是环保轻型张,颜色偏黄,重量比较轻。
- ● 毛边版:即书翻页的地方,故意做成了参差不齐的样子,一般为精装版,更具收藏价值。
关于退换货:
- 由于预订产品的特殊性,采购订单正式发订后,买方不得无故取消全部或部分产品的订购。
- 由于进口图书的特殊性,发生以下情况的,请直接拒收货物,由快递返回:
- ● 外包装破损/发错货/少发货/图书外观破损/图书配件不全(例如:光盘等)
并请在工作日通过电话400-008-1110联系我们。
- 签收后,如发生以下情况,请在签收后的5个工作日内联系客服办理退换货:
- ● 缺页/错页/错印/脱线
关于发货时间:
- 一般情况下:
- ●【现货】 下单后48小时内由北京(库房)发出快递。
- ●【预订】【预售】下单后国外发货,到货时间预计5-8周左右,店铺默认中通快递,如需顺丰快递邮费到付。
- ● 需要开具发票的客户,发货时间可能在上述基础上再延后1-2个工作日(紧急发票需求,请联系010-68433105/3213);
- ● 如遇其他特殊原因,对发货时间有影响的,我们会第一时间在网站公告,敬请留意。
关于到货时间:
- 由于进口图书入境入库后,都是委托第三方快递发货,所以我们只能保证在规定时间内发出,但无法为您保证确切的到货时间。
- ● 主要城市一般2-4天
- ● 偏远地区一般4-7天
关于接听咨询电话的时间:
- 010-68433105/3213正常接听咨询电话的时间为:周一至周五上午8:30~下午5:00,周六、日及法定节假日休息,将无法接听来电,敬请谅解。
- 其它时间您也可以通过邮件联系我们:customer@readgo.cn,工作日会优先处理。
关于快递:
- ● 已付款订单:主要由中通、宅急送负责派送,订单进度查询请拨打010-68433105/3213。
本书暂无推荐
本书暂无推荐